Department of Ophthalmology and Vision Science, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai 200031, China.
NHC Key Laboratory of Myopia, Laboratory of Myopia, Chinese Academy of Medical Sciences, Fudan University, Shanghai 200031, China.
Dis Markers. 2022 Nov 23;2022:4259067. doi: 10.1155/2022/4259067. eCollection 2022.
This study is aimed at investigating the difference of meibum chemokines in MGD subjects with different degrees of MGD and the correlations of meibum chemokines with ocular surface parameters.
Twenty MGD subjects (MQ score > 8) and twenty MGD subjects (MQ score ≤ 8) were enrolled to examine ocular surface parameters, including meibomian gland function (MGE, MQ meibograde, and lid margin), tear stability (NIKBUT, FBUT, and LLT), tear secretion (SIT and TMH), OSDI questionnaire, and CFS. These subjects also obtained meibum samples, and then meibum chemokines (MIG, IFN-, IL-8, IP-10, and MCP-1) were examined and analyzed the correlations with ocular surface parameters.
MIG, IP-10, and MCP-1 were found clearly elevated in MGD subjects with higher MQ score than that in MGD subjects with low MQ score (MIG: = 0.038, IP-10: = 0.019, MCP-1: = 0.040). The meibomian function was found mostly positively correlated with level of MIG (MGE: = 0.600, < 0.001; MQ: = 0.579, < 0.001) and IP-10 (MGE: = 0.719, < 0.001; MQ: = 0.601, < 0.001). The tear stability was found negatively correlated with the level of MIG (NIKBUT: = -0.438, = 0.005; LLT: = -0.464, = 0.003) and MCP-1 (NIKBUT: = -0.425, = 0.006; LLT: = -0.761, < 0.001). The OSDI was positively correlated with IL-8, IFN-, and MIG.
Chemokines in meibum were significantly evaluated in MGD subjects suffering from severe meibomian gland quality. These findings indicate that chemokines play roles in the pathogenesis of MGD, and molecules targeted by chemokines may develop as novel agents for MGD therapy, perhaps through inhibiting inflammation in meibomian glands and microvascular in the eyelid margin.
本研究旨在探讨不同严重程度的睑板腺功能障碍(MGD)患者的睑脂趋化因子的差异,以及睑脂趋化因子与眼表参数的相关性。
纳入 20 例 MGD 患者(MQ 评分>8)和 20 例 MGD 患者(MQ 评分≤8),检查眼表参数,包括睑板腺功能(MGE、MQ 睑板腺分级和睑缘)、泪膜稳定性(NIBUT、FBUT 和 LLT)、泪液分泌(SIT 和 TMH)、OSDI 问卷和 CFS。这些患者还获得了睑脂样本,然后检查和分析了睑脂趋化因子(MIG、IFN-γ、IL-8、IP-10 和 MCP-1),并分析了它们与眼表参数的相关性。
与 MQ 评分较低的 MGD 患者相比,MGD 患者中 MIG、IP-10 和 MCP-1 明显升高(MIG:=0.038,P=0.019,MCP-1:=0.040)。睑板腺功能与 MIG 水平呈正相关(MGE:=0.600,P<0.001;MQ:=0.579,P<0.001)和 IP-10(MGE:=0.719,P<0.001;MQ:=0.601,P<0.001)。泪膜稳定性与 MIG(NIBUT:=-0.438,P=0.005;LLT:=-0.464,P=0.003)和 MCP-1(NIBUT:=-0.425,P=0.006;LLT:=-0.761,P<0.001)水平呈负相关。OSDI 与 IL-8、IFN-γ和 MIG 呈正相关。
本研究对患有严重睑板腺质量的 MGD 患者的睑脂趋化因子进行了评估。这些发现表明趋化因子在 MGD 的发病机制中起作用,趋化因子的靶向分子可能作为 MGD 治疗的新型药物发展,或许可以通过抑制睑板腺和睑缘微血管的炎症。